يعرض 3,021 - 3,040 نتائج من 6,089 نتيجة بحث عن '(( significantly ((linked decrease) OR (linear decrease)) ) OR ( significant genes decrease ))', وقت الاستعلام: 0.64s تنقيح النتائج
  1. 3021
  2. 3022
  3. 3023
  4. 3024
  5. 3025

    Investigating the Impact of Base Pair Mismatches on Cas13d Cleavage Efficiency Using Molecular Dynamics Simulations حسب Ye Liu (296340)

    منشور في 2025
    "…However, the presence of mismatches significantly undermines the cleavage efficiency of Cas13d to target RNA. …"
  6. 3026
  7. 3027
  8. 3028
  9. 3029
  10. 3030
  11. 3031
  12. 3032
  13. 3033
  14. 3034

    Increased <i>Huwe1</i> after induction of Sox2 in mouse ES cells. حسب Yen-Fu Cheng (5819855)

    منشور في 2025
    "…<i>Atoh1</i> expression increased with <i>Sox2</i> at low levels but decreased at higher <i>Sox2</i> level. The relative expression of each gene increased significantly (*p < 0.05) compared to untreated controls (no Dox). …"
  15. 3035

    List of primers used in quantitative RT-PCR. حسب Tarek A. Essa (22430744)

    منشور في 2025
    "…The results demonstrated that NPs significantly reduced basal rot symptoms and decreased the Area Under the Disease Progress Curve (AUDPC) values. …"
  16. 3036

    Table_2_Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis.xls حسب Ying He (125930)

    منشور في 2025
    "…We found that Sunitinib significantly decreased the endometriotic lesion size and weight after 1 and 3 weeks, and decreased p-STAT3 activation in MDSCs after 1 week of treatment. …"
  17. 3037

    Table_3_Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis.xls حسب Ying He (125930)

    منشور في 2025
    "…We found that Sunitinib significantly decreased the endometriotic lesion size and weight after 1 and 3 weeks, and decreased p-STAT3 activation in MDSCs after 1 week of treatment. …"
  18. 3038

    Table_1_Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis.xlsx حسب Ying He (125930)

    منشور في 2025
    "…We found that Sunitinib significantly decreased the endometriotic lesion size and weight after 1 and 3 weeks, and decreased p-STAT3 activation in MDSCs after 1 week of treatment. …"
  19. 3039
  20. 3040